囊性纤维化呼吸道上皮质对CFTR调节器治疗的转录和功能反应
Eszter K Vladar1, Austin E Gillen1,2, Sangya Yadav1
1Department of Medicine, University of Colorado, Aurora, Colorado, USA.
JCI insight
|November 10, 2025
概括
通过减少炎症和重塑,elexacaftor/tezacaftor/ivacaftor (ETI) 疗法可以改善囊性纤维化 (CF) 的气道. 然而,长期使用可能会出现炎症的复发,这表明需要持续监测.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 微生物学 微生物学
背景情况:
- 囊性纤维化 (CF) 呼吸道疾病在使用Elexacaftor/tezacaftor/ivacaftor (ETI) CFTR调制剂治疗时显著改善.
- 长期的分子和细胞机制,疗效以及ETI的气道重塑逆转仍然不清楚.
研究的目的:
- 在两年内调查CF气道疾病中ETI治疗的分子和细胞机制.
- 为了评估基因表达,细胞组成,干细胞功能和ETI治疗后的微生物组变化.
主要方法:
- 从成年CF患者的长度鼻刷样本在基线,在ETI启动6个月和2年后被分析.
- 评估了基因表达,细胞组成,气道上皮干细胞分化,屏障能力和微生物群.
主要成果:
- 在6个月内,ETI治疗导致了显著的中性恋炎症降低和改善肺功能.
- 空气道上皮干细胞显示部分改善了分化和屏障能力.
- 虽然临床结果保持稳定,但转录分析显示,在6个月至2年之间,炎症基因表达的复苏.
- 在研究期间,伪omonas的相对丰度下降.
结论:
- 在CF患者中,ETI治疗有效降低了呼吸道炎症,上皮重塑和细菌感染.
- 炎症基因表达的复苏表明正在进行的炎症可能需要长期监测.
- 这些发现提供了关于ETI对CF气道疾病机制的长期影响的见解.
相关概念视频
Cystic Fibrosis: Management
457
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
457
Cystic Fibrosis: Pathogenesis
693
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
693


